Preparation method of drug for treating cerebrovascular disease sequelae
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for cerebrovascular disease and sequelae, applied in the field of medicine, can solve problems such as long treatment cycle, high cost, and poor treatment effect, and achieve effective treatment, obvious effect, and reasonable composition
Inactive Publication Date: 2015-08-05
孙景芝
View PDF1 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, a small amount of western medicine is used to treat the sequelae of cerebrovascular disease, but long-term infusion, taking antihypertensive and blood lipid-lowering drugs can only lower blood pressure and relieve heart function, but cannot remove thrombus, dilate blood vessels, nourish qi and blood, Good circulatory effects such as sperm production and fluid production, the treatment effect is not good, the treatment cycle is long, and the cost is high
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment
[0010] Example Preparation of the decoction of the present invention
[0011] Take 90 grams of Lamb Qilian, 80 grams of Cycas fern, 80 grams of Guojiang Longzi, 70 grams of Dushangshan, 70 grams of Ling vanilla, 60 grams of chicken tendon, 60 grams of green sky sunflower, 50 grams of medicinal inverted pot, 50 grams of bell beans, 30 grams of yellow water sticks, 20 grams of sugar root and 10 grams of licorice, add 11,000 ml of water, heat for 6 hours under reflux conditions, filter, and cool the filtrate to room temperature.
experiment example
[0013] Diagnostic criteria
[0014] The diagnostic standard of Chinese medicine adopts "Stroke Diagnosis and Efficacy Evaluation Criteria" (Ren Zhanli, Wang Shundao. Diagnosis and Efficacy Evaluation Criteria of Stroke. Journal of Beijing University of Chinese Medicine, 1996, 19(1); 55-56.), Western medicine diagnostic criteria reference "Key points in the diagnosis of various cerebrovascular diseases" (Wang Xinde. Key points in the diagnosis of various cerebrovascular diseases. Chinese Journal of Neurology, 1996, 29(6); 379-381.).
[0015] standard constrain
[0016] ① 24 hours after the onset of cerebral thrombosis, 48 hours after the onset of cerebral hemorrhage, the sequelae of cerebrovascular disease was confirmed by CT. The infarct position is in the basal ganglia and temporal lobe, and the infarct range is ≤18cm 2 . The bleeding site is in the basal ganglia, subarachnoid space, brain lobe, cerebellum, and the amount of bleeding is ≤20ml; ②The syndrome differentiation of tr...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a preparation method of a drug for treating cerebrovascular disease sequelae. The preparation method comprises the following steps: taking 90g of colysis elliptica, 80g of brainea insignis, 80g of bauhinia seed, 70g of maesa japonica, 70g of lysimachia foenum-graecum, 60g of damnacanthus macrophyllus sieb.ex mig.var giganteus(makion)koidz, 60g of nervilia fordii, 50g of dog bur, 50g of crotalaria albida, 30g of tiarella polyphylla, 20g of capitellate hedyotis herb and 10g of liquorice; adding 11000ml of water to heat under backflow condition for 6h; and filtering an cooling the filtrate to room temperature. The drug for treating cerebrovascular disease sequelae is reasonable in composition and remarkable in effect and can be used for effectively treating the cerebrovascular disease sequelae.
Description
Technical field [0001] The invention relates to the field of medicine, in particular to a method for preparing a medicine for treating sequelae of cerebrovascular disease. Background technique [0002] Cerebrovascular disease refers to a group of diseases with cerebral hemorrhagic or ischemic injury symptoms as the main clinical manifestations caused by rupture of cerebral blood vessels or thrombosis. It is commonly known as "stroke". The disease is relatively high among middle-aged and elderly people. The incidence rate is more men than women. After the disease has been treated in the hospital in time and reached clinical treatment, there will still be sequelae such as mild paralysis or hemiplegia, limb numbness, sensory disturbance, movement disorder, dysphonia, ataxia, dizziness, tinnitus, diplopia and other sequelae. At present, a small amount of western medicine is used to treat the sequelae of cerebrovascular disease, and long-term infusion, taking antihypertensive and hyp...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more